JESSICA NARRETT: Open Payments
NPI 1053832790 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 16 payments from 9 companies in 2025. Trend: 2023 $662 · 2024 $1,050 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $150 |
| Astellas Pharma US Inc | 4 | $97 |
| ABBVIE INC. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: Ozempic, Veozah, VRAYLAR, Wegovy, CAPLYTA, FARXIGA, EVENITY, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
